Lecture on Development of Cancer Vaccines Honors A Late Fox Chase Cancer Center Doctor
PHILADELPHIA (April 6, 1999) -- The development of cancer vaccines will be the topic of this year's Robert L. Krigel Endowed Lecture at Fox Chase Cancer Center delivered by Steven A. Rosenberg, M.D., Ph.D., Chief of Surgery at the National Cancer Institute. Dr. Rosenberg is internationally recognized for his numerous contributions to the field of cancer immunotherapy. His topic will be "the development of cancer vaccines based on the genes that encode cancer antigens." This free lecture will be April 30th at 4:00 p.m. at the Center Auditorium at Fox Chase Cancer Center.
The Robert L. Krigel Endowed Lecture was created to honor Dr. Krigel's exceptional work and dedication to Fox Chase before his death in 1994. Dr. Krigel was a graduate from the University of Pennsylvania and received his degree in medicine from Mt. Sinai School of Medicine. After completing his internal medicine residency and chief residency at SUNY-Downstate, Dr. Krigel trained in Hematology/Oncology at New York University. While on staff at NYU, he became a leading authority on the management of AIDS-related malignancies. Dr. Krigel moved to Fox Chase Cancer Center in 1984 as Director of Hematology, where he conducted pioneering clinical studies of combination cytokine therapies in cancer. His impact on Fox Chase cannot be measured solely by examining his impressive research accomplishments. He was an extraordinary clinician, educator and role model, who tirelessly devoted himself to the welfare of Fox Chase.
In 1993 Dr. Krigel was appointed Director of the Lankenau Cancer Center. Shortly after establishing himself there, he was diagnosed with angiosarcoma, which took his life in April, 1994.
R.S.V.P. for the lecture must be taken by April 21 by calling 215-728-2480.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. Fox Chase activities include basic and clinical research; prevention, detection, and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).